Moreover, sodium butyrate was reported to improve aversive memory impairment, depression-like behaviors, and hippocampal microglial activation via inhibiting histone deacetylase and increasing the levels of Ten-Eleven Translocation 1 (TET1), 5-HT, and BDNF expression [99–101]. Here, TET1 is linked to depressive symptom measurement.